CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 30 enrolled
Drug / intervention
Chondron(autologous chondrocyte) Implantationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01050816
NCT01050816Phase 3Completed
CompareCT.gov

An Investigator Clinical Trial to Observe Effects of CHONDRON (Autologous Chondrocytes) for 12 Months in Patients With Ankle Cartilage Defect

Cellontech Co., Ltd.·interventional·Posted Jan 15, 2010·Updated May 11, 2010

In Brief

A Phase 3 clinical trial evaluating Chondron(autologous chondrocyte) Implantation for Articular Cartilage Defects of Ankle Joint. Completed, enrolled 30 participants across 1 site.

Detailed Summary

An open clinical trial transplanting CHONDRON (autologous chondrocytes) to ankle cartilage defect patients who are appropriate for the trial, and evaluating the validity and safety for 12 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArticular Cartilage Defects of Ankle Joint
CountriesSouth Korea
Collaborators--

Timeline

Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 15, 2010
Enrollment StartJan 1, 2006
Primary CompletionJan 1, 2009
Study CompletionFeb 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 16.5 years ago

Interventions

Chondron(autologous chondrocyte) Implantationprocedure

* Test drug: Chondron (more than 12 million chondrocytes in 0.4ml, i.e. 1 vial) * Directions and dosage: Suspend the cells in the vial sufficiently, and implant them in the defective part, making sure that sufficient amounts are injected. \*30 subjects participated in this open clinical trial. Those who agreed to participate voluntarily went through screening to confirm the appropriateness for the clinical trial, and then received Gel type CHONDRON (fibrin mixed autologous chondrocytes) transplantation.